These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1563014)

  • 1. Complement-dependent lysis of tumor cells by a baboon IgM antibody to a tumor-associated antigen.
    Hunt KK; Shibata M; Gupta RK; Morton DL
    Cancer Immunol Immunother; 1992; 34(6):377-82. PubMed ID: 1563014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning of a human antibody directed against human neuroblastoma cells and specific for human translation elongation factor 1alpha.
    Schilbach K; Kreyenberg H; Geiselhart A; Niethammer D; Handgretinger R
    Tissue Antigens; 2004 Feb; 63(2):122-31. PubMed ID: 14705983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human monoclonal antibody to tumor-associated ganglioside GD2.
    Katano M; Saxton RE; Irie RF
    J Clin Lab Immunol; 1984 Nov; 15(3):119-26. PubMed ID: 6099419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human monoclonal antibody to ganglioside GD2-inhibited human melanoma xenograft.
    Katano M; Jien M; Irie RF
    Eur J Cancer Clin Oncol; 1984 Aug; 20(8):1053-9. PubMed ID: 6540688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cytolysis of human neuroblastoma cells by a natural IgM 'antibody'-complement system in pregnancy serum.
    Bolande RP; Mayer DC
    Cancer Invest; 1990; 8(6):603-11. PubMed ID: 2292053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of a well-characterized tumor-associated antigen on melanoma cell surface.
    Wong JH; Gupta RK; Morton DL
    J Surg Oncol; 1988 Jul; 38(3):147-50. PubMed ID: 3292843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of antibodies to a tumor-associated antigen by immunization with a whole melanoma cell vaccine.
    Euhus DM; Gupta RK; Morton DL
    Cancer Immunol Immunother; 1989; 29(4):247-54. PubMed ID: 2752392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine monoclonal IgG3 antibodies to human colorectal tumor-associated antigens: production and characterization of antibodies active in both antibody-dependent cellular cytotoxicity and complement-mediated cytolysis.
    Woodhouse CS; Morgan AC
    Cancer Res; 1989 May; 49(10):2766-72. PubMed ID: 2713860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody of patients with Guillain-Barré syndrome mediates complement-dependent cytolysis of rat Schwann cells: susceptibility to cytolysis reflects Schwann cell phenotype.
    Sawant-Mane S; Estep A; Koski CL
    J Neuroimmunol; 1994 Jan; 49(1-2):145-52. PubMed ID: 8294552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new recombinant single chain trispecific antibody recruits T lymphocytes to kill CEA (carcinoma embryonic antigen) positive tumor cells in vitro efficiently.
    Wang XB; Zhao BF; Zhao Q; Piao JH; Liu J; Lin Q; Huang HL
    J Biochem; 2004 Apr; 135(4):555-65. PubMed ID: 15115782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin inhibition of antibody-dependent complement-mediated lysis.
    Wesolowski J; Ault K; Houghton R; Parkman R
    Exp Hematol; 1984 Oct; 12(9):700-5. PubMed ID: 6237929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between allo-immunoreactive and xeno-immunoreactive subunits of a glycoprotein tumor-associated antigen.
    Euhus DM; Gupta RK; Morton DL
    Cancer Immunol Immunother; 1990; 32(4):214-20. PubMed ID: 1702032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disialoganglioside GD3 on human melanoma serves as a relevant target antigen for monoclonal antibody-mediated tumor cytolysis.
    Cheresh DA; Honsik CJ; Staffileno LK; Jung G; Reisfeld RA
    Proc Natl Acad Sci U S A; 1985 Aug; 82(15):5155-9. PubMed ID: 3860849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral response of melanoma patients to two different tumor-associated antigens.
    Chee DO; Gupta RK; Morton DL
    J Surg Oncol; 1983 Aug; 23(4):228-35. PubMed ID: 6876798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and immunochemical characterization of antibodies from the sera of cancer patients which are reactive against human melanoma cell membranes by affinity chromatography.
    Gupta RK; Silver HK; Reisfeld RA; Morton DL
    Cancer Res; 1979 May; 39(5):1683-95. PubMed ID: 427806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
    Weinhold KJ; Wheelock EF
    Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological characterization of a chimeric mouse-human IgM antibody directed against the 17-1A antigen.
    Fogler WE; Sun LK; Klinger MR; Ghrayeb J; Daddona PE
    Cancer Immunol Immunother; 1989; 30(1):43-50. PubMed ID: 2598174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgM monoclonal antibody JD118 recognizes an inducible antigen target for human-complement-mediated cytotoxicity against neoplastic B cells.
    Czuczman MS; Garin-Chesa P; Lemoli RM; Scheinberg DA
    Cancer Immunol Immunother; 1993 Jun; 36(6):387-96. PubMed ID: 8500111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of antibody-complement-mediated killing of tumor cells by hormones.
    Schlager SI; Ohanian SH; Borsos T
    Cancer Res; 1976 Oct; 36(10):3672-7. PubMed ID: 182362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-GM(2) IgM antibody-induced complement-mediated cytotoxicity in patients with dysimmune neuropathies.
    Cavanna B; Jiang H; Allaria S; Carpo M; Scarlato G; Nobile-Orazio E
    J Neuroimmunol; 2001 Mar; 114(1-2):226-31. PubMed ID: 11240036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.